JAK3-IN-9 is a potent and orally active inhibitor of the Janus kinase 3 (JAK3) enzyme, displaying an impressive IC50 value of 1.7 nM. It exhibits high selectivity towards the JAK3 signaling pathway, making it a valuable tool for studying autoimmune diseases. Additionally, JAK3-IN-9 possesses desirable characteristics such as low toxicity and excellent oral bioavailability. It also demonstrates promising anti-arthritis activity, thus enhancing its potential as a therapeutic agent [1].
Molecular Weight:
393.46
CAS Number:
[1430095-30-9]
Formula:
C17H23N5O4S
Target:
Others|||JAK
T61814
* VAT and and shipping costs not included. Errors and price changes excepted
